Bicycle Therapeutics plcBCYCNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank25
3Y CAGR+20.6%
5Y CAGR-24.5%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+20.6%/yr
vs -40.0%/yr prior
5Y CAGR
-24.5%/yr
Recent acceleration
Acceleration
+60.6pp
Accelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 19.44% |
| 2023 | 20.86% |
| 2022 | 52.63% |
| 2021 | 11.07% |
| 2020 | 100.56% |
| 2019 | 79.29% |
| 2018 | 26.75% |
| 2017 | 85.55% |
| 2016 | 0.00% |